These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
838 related articles for article (PubMed ID: 27997526)
1. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526 [TBL] [Abstract][Full Text] [Related]
2. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521 [TBL] [Abstract][Full Text] [Related]
3. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report]. Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308 [No Abstract] [Full Text] [Related]
4. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center]. Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523 [TBL] [Abstract][Full Text] [Related]
6. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation. Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984 [TBL] [Abstract][Full Text] [Related]
7. 'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study. Mitrea D; Barbet N; Pacé-Loscos T; Scouarnec C; Ben-Dhia S; Baron D; Mineur L; Évesque L; Durand-Labrunie J; Gérard JP; Baudin G; Doyen J Cancer Radiother; 2024 Aug; 28(4):323-332. PubMed ID: 39003168 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience. Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909 [TBL] [Abstract][Full Text] [Related]
9. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study. Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125 [TBL] [Abstract][Full Text] [Related]
10. Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. Bach SP; Gilbert A; Brock K; Korsgen S; Geh I; Hill J; Gill T; Hainsworth P; Tutton MG; Khan J; Robinson J; Steward M; Cunningham C; Levy B; Beveridge A; Handley K; Kaur M; Marchevsky N; Magill L; Russell A; Quirke P; West NP; Sebag-Montefiore D; Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):92-105. PubMed ID: 33308452 [TBL] [Abstract][Full Text] [Related]
11. Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign. Rupinski M; Szczepkowski M; Malinowska M; Mroz A; Pietrzak L; Wyrwicz L; Rutkowski A; Bujko K Eur J Surg Oncol; 2016 Feb; 42(2):288-96. PubMed ID: 26506863 [TBL] [Abstract][Full Text] [Related]
12. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854 [TBL] [Abstract][Full Text] [Related]
13. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J; BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495 [TBL] [Abstract][Full Text] [Related]
14. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy]. Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534 [TBL] [Abstract][Full Text] [Related]
15. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes. Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323 [TBL] [Abstract][Full Text] [Related]
16. Management of Rectal Cancer Without Radical Resection. Beets GL; Figueiredo NF; Beets-Tan RG Annu Rev Med; 2017 Jan; 68():169-182. PubMed ID: 27618750 [TBL] [Abstract][Full Text] [Related]
17. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study. Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW; JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338 [TBL] [Abstract][Full Text] [Related]
18. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer. Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983 [TBL] [Abstract][Full Text] [Related]
19. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Dossa F; Chesney TR; Acuna SA; Baxter NN Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372 [TBL] [Abstract][Full Text] [Related]
20. Local excision following chemoradiotherapy in T2-T3 rectal cancer: current status and critical appraisal. Peltrini R; Sacco M; Luglio G; Bucci L Updates Surg; 2020 Mar; 72(1):29-37. PubMed ID: 31621033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]